Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis

Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary EventsSignificance

(2016) Harry Björkbacka et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Adaptive Response of T and B Cells in Atherosclerosis

(2016) Daniel F.J. Ketelhuth et al.   CIRCULATION RESEARCH

Modulation of Autoimmunity and Atherosclerosis　– Common Targets and Promising Translational Approaches Against Disease –

(2015) Daniel FJ Ketelhuth et al.   CIRCULATION JOURNAL

Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes

(2015) Sinu Paul et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The immune epitope database (IEDB) 3.0

(2014) Randi Vita et al.   NUCLEIC ACIDS RESEARCH

Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses

(2014) Yajuan Wang et al.   THROMBOSIS AND HAEMOSTASIS

T Cell-based Therapies for Atherosclerosis

(2013) Daniel Ketelhuth et al.   CURRENT PHARMACEUTICAL DESIGN

NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ

(2013) Edita Karosiene et al.   IMMUNOGENETICS

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100

(2013) Kevin Tse et al.   Frontiers in Immunology

Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques

(2013) Shijie Li et al.   Molecular Metabolism

Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

(2012) Olivier Herbin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Unknown

(2012) Lasse Folkersen et al.   MOLECULAR MEDICINE

Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses

(2011) Daniel F.J. Ketelhuth et al.   CIRCULATION

Immunotherapy With Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice

(2011) Andreas Hermansson et al.   CIRCULATION

Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes

(2011) Jason Greenbaum et al.   IMMUNOGENETICS

Cellular immunity, low-density lipoprotein and atherosclerosis: Break of tolerance in the artery wall

(2011) Daniel Ketelhuth et al.   THROMBOSIS AND HAEMOSTASIS

Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis

(2010) Roland Klingenberg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE−/− mice

(2010) Yanice V. Mendez-Fernandez et al.   ATHEROSCLEROSIS

Peptide binding predictions for HLA DR, DP and DQ molecules

(2010) Peng Wang et al.   BMC BIOINFORMATICS

Association of Genetic Risk Variants With Expression of Proximal Genes Identifies Novel Susceptibility Genes for Cardiovascular Disease

(2010) Lasse Folkersen et al.   Circulation-Cardiovascular Genetics

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

(2010) Andreas Hermansson et al.   JOURNAL OF EXPERIMENTAL MEDICINE

FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice

(2010) Ming Zhao et al.   JOURNAL OF IMMUNOLOGY

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine

(2010) M. Wigren et al.   JOURNAL OF INTERNAL MEDICINE

Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice

(2009) Kim L.L. Habets et al.   CARDIOVASCULAR RESEARCH

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies

(2009) Roland Klingenberg et al.   EUROPEAN HEART JOURNAL

High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction

(2008) P. Sjogren et al.   EUROPEAN HEART JOURNAL

Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies

(2008) G. N. Fredrikson et al.   JOURNAL OF INTERNAL MEDICINE

Autoantibody Response to Chromatographic Fractions from Oxidized LDL in Unstable Angina Patients and Healthy Controls

(2008) D. F. J. Ketelhuth et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY